Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
Peter A. Everts, Senior Director Medical Affairs at Bioventus, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
”We are excited to share our new review in the Journal of Clinical Medicine: ‘Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies?’
PRP is used in orthopedics and sports medicine on a daily basis, yet outcomes stay inconsistent.
We argue that the field has focused heavily on platelet dosing, and not as much on PRP bioformulations and platelet phenotypes.
Larger, denser, younger platelets carry far more granular content, factors that actually drive repair.
Our recommendation: measure platelet indices (MPV, PDW, density) before preparing PRP, and use protocols that recover these denser, more reactive platelets—rather than treating platelet density as a fixed value.
We present this as a grounded hypothesis: the mechanistic links are well supported, but proving that high-MPV enrichment improves outcomes awaits prospective trials. That’s the work we hope this prompts.”
Title: Are Platelet Volume, Density, and the Homeostatic Blueprint the Missing Link in Platelet-Rich Plasma Therapies? An Evidence-Based Narrative Review
Authors: Peter A. Everts, Luga Podesta, Jane Fitzpatrick, Leonardo P. Oliveira, José Fábio Lana, André van Zundert, Mikel Sánchez, Diego Delgado, Christine Brown Mahoney, Glenn Flanagan, Robert Alexander, Paul Harrison
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?